Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04248699 · ClinicalTrials.gov registry record · NA
Lumenato Nutritional Supplement on Skin Appearance
A NA study of Skin, sponsored by LycoRed.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT04248699: Completed NA study of Skin, sponsored by LycoRed.
NCT04248699 is a NA study of Skin that has completed, run by LycoRed. The registered enrollment target is 72 participants, above the 52-participant average among 5 other Skin trials with a reported enrollment target (38% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04248699, a NA study of Skin, has completed, sponsored by LycoRed.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
This 12-week study is an open-label study assessing the perceived effectiveness of the Lycored Lumenato supplement on skin health and appearance.
Primary Outcome
FACE-Q™ Satisfaction with Skin scale: gathers the participant perspective of their satisfaction or dissatisfaction with their facial skin using a 12-question scale. Participants are asked to choose one of the following responses for each question: Very Dissatisfied (1), Somewhat Dissatisfied (2), Somewhat Satisfied (3) and Very Satisfied (4) for each 12 questions and the sum of scores (or mean of the completed items, in the event of an incomplete scale) gets converted into a score from 0 (worst)
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Lumenato
Study Locations (1)
Florida
- o ObvioHealth - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2020-01-14 |
| Est. Completion | 2020-07-08 |
| Phase | NA |
What the finished NCT04248699 record still lists
NCT04248699 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, above the 52-participant average among 5 other Skin trials with a reported enrollment target (38% higher).
The record links to 1 condition, with Skin appearing as the primary indexed condition, and to 1 intervention - of which Lumenato is the first listed.
NCT04248699 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04248699 about?
NCT04248699 is a clinical study titled "Lumenato Nutritional Supplement on Skin Appearance". This 12-week study is an open-label study assessing the perceived effectiveness of the Lycored Lumenato supplement on skin health and appearance.
What is the current status of trial NCT04248699?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2020-01-14. Estimated completion is 2020-07-08.
What conditions does trial NCT04248699 study?
This clinical trial studies the following conditions: Skin.
What interventions are being tested in trial NCT04248699?
The interventions under investigation include: Lumenato (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04248699?
This trial is sponsored by LycoRed, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04248699 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
See the Impact Beem's Blue Light Therapy Has on Your Skin Health!
RECRUITING · NA
-
The Effect of Topical Almond Oil vs. Topical Retinol on The Appearance of Facial Wrinkles
COMPLETED · NA
-
A Clinical Study to Evaluate the Efficacy and Consumer Perception of Lumenato
COMPLETED · NA
-
Trial of Ixazomib for Kaposi Sarcoma
RECRUITING · Phase 2
-
In Vivo Cross-Modal Imaging of Skin
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI